Evidence map›Paper›PMID 28315672›Full record

ArticleThe Journal of molecular diagnostics : JMD2017

Principles and Recommendations for Standardizing the Use of the Next-Generation Sequencing Variant File in Clinical Settings.

Ira M Lubin, Nazneen Aziz, Lawrence J Babb, Dennis Ballinger, Himani Bisht, Deanna M Church, Shaun Cordes, Karen Eilbeck, Fiona Hyland, Lisa Kalman and 14 more

Abstract read
In one paragraph

Article in The Journal of molecular diagnostics : JMD, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. The Use of AI for Phenotype-Genotype Mapping.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. How Can Law and Policy Advance Quality in Genomic Analysis and Interpretation for Clinical Care?The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2020
    Article
  6. Article
  7. Article
  8. FHIR Lab Reports: using SMART on FHIR and CDS Hooks to increase the clinical utility of pharmacogenomic laboratory test results.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2020
    Article
  9. Implementing the VMC Specification to Reduce Ambiguity in Genomic Variant Representation.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Ira M LubinDivision of Laboratory Systems, Centers for Disease Control and Prevention, Atlanta, Georgia. Electronic address: ilubin@cdc.gov.
Nazneen AzizCollege of American Pathologists, Chicago, Illinois; Kaiser Permanente Research Bank, Oakland, California.
Lawrence J BabbPartners Healthcare Personalized Medicine, Cambridge, Massachusetts; GeneInsight, a Sunquest Company, Boston, Massachusetts.
Dennis BallingerComplete Genomics, Mountain View, California.
Himani BishtCenter for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland.
Deanna M ChurchPersonalis, Menlo Park, California; National Center for Biotechnology Information, NIH, Bethesda, Maryland; 10× Genomics, Pleasanton, California.
Shaun CordesComplete Genomics, Mountain View, California.
Karen EilbeckDepartment of Human Genetics, University of Utah School of Medicine, Salt Lake City, Utah.
Fiona HylandLife Technologies, Carlsbad, California.
Lisa KalmanDivision of Laboratory Systems, Centers for Disease Control and Prevention, Atlanta, Georgia.
Melissa LandrumNational Center for Biotechnology Information, NIH, Bethesda, Maryland.
Edward R LockhartDivision of Laboratory Systems, Centers for Disease Control and Prevention, Atlanta, Georgia.
Donna MaglottNational Center for Biotechnology Information, NIH, Bethesda, Maryland.
Gabor MarthDepartment of Biomedical Informatics, University of Utah School of Medicine, Salt Lake City, Utah; Boston College, Chestnut Hill, Massachusetts.
John D PfeiferDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri.
Heidi L RehmDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Somak RoyDivision of Molecular and Genomic Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Zivana TezakCenter for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland.
Rebecca TrutyComplete Genomics, Mountain View, California; Invitae Corporation, San Francisco, California.
Mollie Ullman-CullereDana-Farber Cancer Institute and Partners Healthcare, Boston, Massachusetts.
Karl V VoelkerdingDepartment of Pathology, University of Utah and the Institute for Clinical and Experimental Pathology, Associated Regional and University Pathologists Laboratories, Salt Lake City, Utah.
Elizabeth A WortheyDepartment of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin.
Alexander W ZaranekPersonal Genome Project, Harvard Medical School, Boston, Massachusetts; Curoverse, Inc., Somerville, Massachusetts.
Justin M ZookMaterial Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, Maryland.

Funding

National Biomedical Information ServicesZIHLM200888 · NLM · NATIONAL LIBRARY OF MEDICINE · PI PALTOO, DINA · 2009 to 2025
$5200.7M
Resource ProjectU41HG006834 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI REHM, HEIDI L · 2013 to 2020
$26.9M
A Community Driven Framework for Genome Based Clinical DiagnosticsR01HG008628 · NHGRI · UNIVERSITY OF UTAH · PI EILBECK, KAREN LOUISE, MARTH, GABOR T · 2015 to 2017
$1.8M
An Open Source Precision Medicine Platform for Cloud Operating SystemsR44GM109737 · NIGMS · CUROVERSE INNOVATIONS, INC. · PI ZARANEK, ALEXANDER WAIT · 2016 to 2017
$1.5M
An Open Source Precision Medicine Platform for Cloud Operating SystemsR43GM109737 · NIGMS · CUROVERSE, INC. · PI ZARANEK, ALEXANDER WAIT · 2014 to 2015
$300k
NHGRI NIH HHS R01 HG008628NHGRI NIH HHS U41 HG006834NIGMS NIH HHS R43 GM109737NIGMS NIH HHS R44 GM109737
6 · The paper itself

Abstract

A national workgroup convened by the Centers for Disease Control and Prevention identified principles and made recommendations for standardizing the description of sequence data contained within the variant file generated during the course of clinical next-generation sequence analysis for diagnosing human heritable conditions. The specifications for variant files were initially developed to be flexible with regard to content representation to support a variety of research applications. This flexibility permits variation with regard to how sequence findings are described and this depends, in part, on the conventions used. For clinical laboratory testing, this poses a problem because these differences can compromise the capability to compare sequence findings among laboratories to confirm results and to query databases to identify clinically relevant variants. To provide for a more consistent representation of sequence findings described within variant files, the workgroup made several recommendations that considered alignment to a common reference sequence, variant caller settings, use of genomic coordinates, and gene and variant naming conventions. These recommendations were considered with regard to the existing variant file specifications presently used in the clinical setting. Adoption of these recommendations is anticipated to reduce the potential for ambiguity in describing sequence findings and facilitate the sharing of genomic data among clinical laboratories and other entities.

Indexed as

Databases, GeneticGenetic VariationHigh-Throughput Nucleotide SequencingHumansSequence Analysis, DNASoftware

Identifiers

PMID28315672
PMCPMC5417043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.